OpenAI has officially unveiled a comprehensive dual strategy for artificial intelligence in healthcare, introducing both an enterprise-grade suite, 'OpenAI for Healthcare,' and a consumer-facing 'ChatGPT Health.' The enterprise offering, launched on January 8, 2026, includes 'ChatGPT for Healthcare' and the OpenAI API, specifically designed to help medical organizations deliver high-quality care, streamline administrative tasks, and build custom clinical solutions. A critical aspect of this launch is OpenAI's commitment to supporting Health Insurance Portability and Accountability Act (HIPAA) compliance, providing features like Business Associate Agreements (BAAs), data residency options, audit logs, and customer-managed encryption keys. Importantly, content shared within these enterprise tools is not used for model training. Simultaneously, OpenAI introduced 'ChatGPT Health' on January 7, 2026, a dedicated, secure space within ChatGPT for individuals to engage in health and wellness conversations. This consumer-focused feature allows users to optionally connect their personal medical records and data from various wellness applications, such as Apple Health and MyFitnessPal, to receive personalized and contextually relevant responses. OpenAI emphasizes that 'ChatGPT Health' is intended to support users in understanding their health information, preparing for medical appointments, and navigating general wellness, rather than providing diagnoses or treatments. The company has implemented enhanced privacy protections, ensuring health conversations are stored separately, encrypted, and not utilized for training foundational AI models. Both initiatives leverage advanced GPT-5.2 models, developed with extensive input from over 260 licensed physicians across 60 countries, who contributed to evaluating more than 600,000 model outputs across 30 areas of focus to ensure performance, safety, and trustworthiness. Several prominent U.S. healthcare institutions, including AdventHealth, Cedars-Sinai Medical Center, and Stanford Medicine Children's Health, are among the early adopters and collaborators for the enterprise suite. While the enterprise solutions target global healthcare organizations, the initial rollout of 'ChatGPT Health' has regional limitations, primarily starting outside the European Economic Area, Switzerland, and the UK, with medical record integration initially available in the U.S. This marks a significant step towards integrating advanced AI into the global healthcare ecosystem.